Stock Report

All about this stock under one free report Last Updated: 05-Nov-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Onyx Biotec Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ONYX

₹36.00

₹0.00 (0.00%)

As on 04-Nov-2026 09:08IST

Market cap

info icon

₹65 Cr

Revenue (TTM)

info icon

₹69 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

1.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 12.13 20.73 --
EBIT -- -- -95.14 -50.85 --
Net Profit -- -- -104.33 -148.80 --
EPS -- -- -104.33 -142.29 --
Book Value -- -- -0.39 25.60 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-26Mar-25Mar-24
EBIT-Margin info 8.16--0.5111.8312.13
Net Margin info 4.76---0.317.856.75
Return on equity info 9.52---0.3912.2516.71
Return on Capital info 9.23--1.1513.6812.85
Return on Assets info 3.74---0.235.995.47
Debt to Equity (x) info ----0.270.221.22

Profitability

View Detailed Peer Comparison

ROCE

1.15

Lower than Peers by 10.06

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
1.15
13.68
12.85
8.21
15.52
Peer Median
11.21
12.19
11.06
9.85
--
ROE

-0.39

Lower than Peers by 8.55

Profit after tax / Average Net worth * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
-0.39
12.25
16.71
10.67
20.47
Peer Median
8.16
9.26
7.17
7.54
--
ROA

-0.23

Lower than Peers by 4.94

Profit after tax / Average Total assets * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
-0.23
5.99
5.47
3.86
9.10
Peer Median
4.71
7.65
3.78
3.99
--
EBIT Margin

0.51

Lower than Peers by 20.86

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
0.51
11.83
12.13
7.59
9.64
Peer Median
21.37
--
12.49
13.66
--
Net Margin

-0.31

Lower than Peers by 4.10

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
-0.31
7.85
6.75
4.66
7.45
Peer Median
3.79
5.63
2.96
2.70
--
Cash Profit Margin

4.08

Higher than Peers by 4.08

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
4.08
12.92
10.24
8.45
10.70
Peer Median
0.00
--
0.00
0.00
--

Growth

View Detailed Peer Comparison

Revenue Growth

12.13

Lower than Peers by 40.72

Year on year growth in net sales

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
12.13
15.27
36.14
-11.99
--
Peer Median
52.85
--
39.85
38.90
--
EBIT Growth

-95.14

Lower than Peers by 308.71

Year on year growth in operating profit (EBIT)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
-95.14
12.37
117.62
-30.69
--
Peer Median
213.56
--
20.42
176.64
--
Net Profit Growth

-104.33

Lower than Peers by 314.39

Year on year growth in profit after tax

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
-104.33
36.31
97.04
-44.98
--
Peer Median
210.06
--
12.85
218.06
--
EPS Growth

-104.33

Lower than Peers by 307.10

Year on year growth in earnings per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
-104.33
0.15
74.57
-44.98
--
Peer Median
202.77
--
33.33
200.00
--
Book Value Growth

-0.39

--

Year on year growth in book value per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
-0.39
119.96
38.93
11.15
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.27

Higher than Peers by 0.09

Total debt / Net worth

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
0.27
0.22
1.22
1.61
0.75
Peer Median
0.19
0.22
0.20
0.19
--
Short term debt to equity ratio

0.16

--

(Short term borrowings / Net worth)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
0.16
0.07
0.12
0.40
0.08
Peer Median
--
--
--
--
--
Current Ratio

1.58

Lower than Peers by 0.82

Current Assets / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
1.58
1.91
1.31
0.72
1.44
Peer Median
2.39
1.99
2.03
1.95
--
Quick Ratio

1.15

Lower than Peers by 3.66

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
1.15
1.29
0.91
0.42
1.17
Peer Median
4.81
--
1.12
1.24
--
Interest Coverage

0.66

Lower than Peers by 2.84

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
0.66
4.21
3.08
5.43
6.86
Peer Median
3.50
4.14
2.98
3.48
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

39.58

Lower than Peers by 10.61

Debtors outstanding / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
39.58
32.66
28.60
12.86
18.76
Peer Median
50.20
--
29.85
41.06
--
Asset Turnover

0.75

Lower than Peers by 2.19

Sales / Average Total Assets

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
0.75
0.75
0.81
0.83
1.22
Peer Median
2.93
--
1.55
3.06
--
Receivable days

125.39

--

Average Debtors / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
125.39
104.88
69.43
62.37
68.49
Peer Median
--
--
--
--
--
Inventory Days

79.18

--

Average Inventory / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
79.18
74.24
52.40
43.36
24.84
Peer Median
--
--
--
--
--
Payable days

121.46

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
121.46
142.32
105.74
97.57
59.40
Peer Median
--
--
--
--
--
Cash Conversion Cycle

83.11

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
83.11
36.80
16.09
8.16
33.92
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
--
21.23
--
--
--
Peer Median
33.08
44.20
39.23
34.42
--
Price / Book Value

1.11

Lower than Peers by 0.85

Current share price divided by book value per share in the latest financial year

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
1.11
1.89
--
--
--
Peer Median
1.96
2.96
2.56
2.03
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
--
--
--
--
--
Peer Median
--
--
--
--
--
EV/EBITDA

18.89

Higher than Peers by 2.07

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
18.89
9.45
5.01
7.61
3.08
Peer Median
16.82
23.15
24.73
22.79
--
Market Cap

62

Higher than Peers by 20

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Onyx Biotec
62
105
--
--
--
Peer Median
41
55
58
40
--
loading...
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds